CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.56
-0.77 (-1.34%)
At close: Sep 18, 2026, 4:00 PM EDT
57.20
+0.64 (1.13%)
After-hours: Sep 18, 2026, 7:59 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.47 billion as of September 18, 2026. Its market cap has increased by 1.80% in one year.
Market Cap
5.47B
Enterprise Value
3.89B
1-Year Change
1.80%
Ranking
Category
Stock Price
$56.56
ChartMarket Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.47B, an increase of 876.42%. That is a compound annual growth rate of 25.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.47B | 9.43% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirum Pharmaceuticals | 6.11B |
| Travere Therapeutics | 5.95B |
| Scholar Rock Holding | 5.65B |
| Dianthus Therapeutics | 5.61B |
| Ligand Pharmaceuticals | 5.61B |
| PTC Therapeutics | 5.56B |
| Cogent Biosciences | 5.54B |
| Definium Therapeutics | 5.16B |